{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:55:57Z","timestamp":1793120157502,"version":"4.5.0"},"reference-count":131,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Breast cancer remains one of the most prevalent malignancies and a leading cause of cancer-related death in women worldwide. Increasing evidence indicates that regulatory T cells (Tregs), a specialized subset of CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells, play a central role in breast cancer initiation, progression, and therapeutic response by shaping an immunosuppressive tumor microenvironment. Tregs originate from both thymic and peripheral differentiation pathways and are characterized by the expression of FoxP3, CD25, CTLA-4, PD-1, and other immune regulatory molecules. In breast cancer, Tregs accumulate within tumor tissues and peripheral blood through chemokine-mediated recruitment, local expansion, and phenotypic conversion, where they suppress antitumor immunity via IL-2 deprivation, inhibitory cytokine secretion, cytolytic activity, metabolic disruption, and checkpoint signaling. Their enrichment is closely associated with tumor immune escape, invasion, metastasis, and poor prognosis. Moreover, emerging therapeutic strategies targeting Tregs, including immune checkpoint blockade, anti-CCR4 antibodies, vaccines, and pathway-modulating agents, have shown promise in restoring antitumor immunity. This review summarizes the origins, phenotypic features, immunosuppressive mechanisms, and clinical relevance of Tregs in breast cancer, and discusses the opportunities and challenges of Treg-centered immunotherapeutic strategies.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1825637","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T06:03:44Z","timestamp":1779775424000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Regulatory T cells in breast cancer drivers of immune suppression and targets for immunotherapy"],"prefix":"10.3389","volume":"17","author":[{"given":"Teng","family":"Pan","sequence":"first","affiliation":[{"name":"Center for Stem Cell and Regenerative Medicine Research, Maternity & Child Healthcare Hospital of Longgang District (Longgang Maternity and Child Institute of Shantou University Medical College)","place":["Shenzhen, China"]},{"name":"Medical Research Institute of Maternal and Child, Maternity & Child Healthcare Hospital of Longgang District (Longgang Maternity and Child Institute of Shantou University Medical College)","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanrui","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Science and Environmental Studies, The Education University of Hong Kong","place":["Hong Kong, Hong Kong SAR, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijie","family":"Ming","sequence":"additional","affiliation":[{"name":"Department of Oncology, Chongqing University Three Gorges Hospital","place":["Chongqing, China"]},{"name":"School of Medicine, Chongqing University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanglin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Breast and Thyroid Surgery Department, Maternity & Child Healthcare Hospital of Longgang District (Longgang Maternity and Child Institute of Shantou University Medical College)","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Pei","sequence":"additional","affiliation":[{"name":"Center for Stem Cell and Regenerative Medicine Research, Maternity & Child Healthcare Hospital of Longgang District (Longgang Maternity and Child Institute of Shantou University Medical College)","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhai","family":"Deng","sequence":"additional","affiliation":[{"name":"Baiyunshan Pharmaceutical General Factory, Guangdong Province Key Laboratory for Core Technology of Chemical Raw Materials and Pharmaceutical Formulations, Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd.","place":["Guangzhou, China"]},{"name":"Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King\u2019s College London","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(25)01635-6","article-title":"The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023","volume":"406","author":"Force","year":"2025","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1623859","article-title":"Endostatin-based anti-angiogenic therapy and immune modulation: mechanisms and synergistic potential in cancer treatment","volume":"16","author":"Sun","year":"2025","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-026-02655-0","article-title":"Breast cancer immunotherapy: mechanisms of immune evasion, biomarkers, and emerging therapeutic strategies","author":"Shichkin","year":"2026","journal-title":"Mol Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202512952","article-title":"Stress-programmed immune niches fuel TNFR2+ Treg activation and drive neoadjuvant chemotherapy resistance in breast cancer","volume":"13","author":"Shao","year":"2026","journal-title":"Adv Sci (Weinh)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"186","DOI":"10.20892\/j.issn.2095-3941.2025.0645","article-title":"Targeting tumor-infiltrating regulatory T cells based on immunometabolism","volume":"23","author":"Li","year":"2026","journal-title":"Cancer Biol Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1731411","article-title":"Integrative multi-omics stratification and translational evaluation of Treg-targeted combination immunotherapy in breast cancer","volume":"15","author":"Kim","year":"2025","journal-title":"Front Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/cells13181526","article-title":"Treg cell therapeutic strategies for breast cancer: holistic to local aspects","volume":"13","author":"Zhang","year":"2024","journal-title":"Cells"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17193172","article-title":"Regulatory T cells in invasive breast cancer: prognosis, mechanisms and therapy","volume":"17","author":"Xu","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1263537","article-title":"Regulatory T cells are associated with the tumor immune microenvironment and immunotherapy response in triple-negative breast cancer","volume":"14","author":"Huang","year":"2023","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adr7934","article-title":"CD4(+)FOXP3Exon2(+) regulatory T cell frequency predicts breast cancer prognosis and survival","volume":"11","author":"Fusco","year":"2025","journal-title":"Sci Adv"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.740588","article-title":"FOXP3\/HAT1 axis controls Treg infiltration in the tumor microenvironment by inducing CCR4 expression in breast cancer","volume":"13","author":"Sarkar","year":"2022","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-22-0654","article-title":"Therapeutic targeting of tumor-infiltrating regulatory T cells in breast cancer","volume":"82","author":"Fattori","year":"2022","journal-title":"Cancer Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/imr.12160","article-title":"tTregs, pTregs, and iTregs: similarities and differences","volume":"259","author":"Shevach","year":"2014","journal-title":"Immunol Rev"},{"key":"B14","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12943-024-02156-y","article-title":"Regulatory T cells in immune checkpoint blockade antitumor therapy","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol Cancer"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1325946","article-title":"Targeting tumor-infiltrating tregs for improved antitumor responses","volume":"15","author":"Qin","year":"2024","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/imr.12165","article-title":"Homeostasis and function of regulatory T cells (Tregs) in vivo: lessons from TCR-transgenic Tregs","volume":"259","author":"Attridge","year":"2014","journal-title":"Immunol Rev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2023.01.004","article-title":"Principles of regulatory T cell function","volume":"56","author":"Dikiy","year":"2023","journal-title":"Immunity"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/immadv\/ltad007","article-title":"Treg-based immunotherapy for antigen-specific immune suppression and stable tolerance induction: a perspective","volume":"3","author":"Sakaguchi","year":"2023","journal-title":"Immunother Adv"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/cells13110959","article-title":"Many faces of regulatory T cells: heterogeneity or plasticity","volume":"13","author":"Blinova","year":"2024","journal-title":"Cells"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202203699","article-title":"The single-cell landscape of intratumoral heterogeneity and the immunosuppressive microenvironment in liver and brain metastases of breast cancer","volume":"10","author":"Zou","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101511","article-title":"A comprehensive single-cell breast tumor atlas defines epithelial and immune heterogeneity and interactions predicting anti-PD-1 therapy response","volume":"5","author":"Xu","year":"2024","journal-title":"Cell Rep Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.it.2023.06.001","article-title":"Targeting the metabolism of tumor-infiltrating regulatory T cells","volume":"44","author":"Wang","year":"2023","journal-title":"Trends Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1101\/2022.02.22.481404","article-title":"Systematic elucidation and pharmacological targeting of tumor-infiltrating regulatory T cell master regulators","volume":"41","author":"Obradovic","year":"2023","journal-title":"Cancer Cell"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-24-3095","article-title":"Depleting IL1R2+ tumor-infiltrating regulatory T cells with an ADCC-prone nanobody construct boosts the efficacy of anti-PD-1 immunotherapy","volume":"85","author":"Arnouk","year":"2025","journal-title":"Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2114282119","article-title":"CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory","volume":"119","author":"Kidani","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.781364","article-title":"A specific CD44lo CD25lo subpopulation of regulatory T cells inhibits anti-leukemic immune response and promotes the progression in a mouse model of chronic lymphocytic leukemia","volume":"13","author":"Goral","year":"2022","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1513421","article-title":"Patterns of immune evasion in triple-negative breast cancer and new potential therapeutic targets: a review","volume":"15","author":"Serrano Garc\u00eda","year":"2024","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00893-7","article-title":"The role of transcription factors in shaping regulatory T cell identity","volume":"23","author":"Trujillo-Ochoa","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/cei\/uxad048","article-title":"Development and function of FOXP3+ regulators of immune responses","volume":"213","author":"Golzari-Sorkheh","year":"2023","journal-title":"Clin Exp Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1444533","article-title":"Epigenetic regulation of human FOXP3+ Tregs: from homeostasis maintenance to pathogen defense","volume":"15","author":"Yue","year":"2024","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1387975","article-title":"Regulation of Treg cells by cytokine signaling and co-stimulatory molecules","volume":"15","author":"Zong","year":"2024","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-023-01036-7","article-title":"Intricacies of TGF-\u03b2 signaling in Treg and Th17 cell biology","volume":"20","author":"Wang","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1345838","article-title":"Reprogramming of regulatory T cells in inflammatory tumor microenvironment: can it become immunotherapy turning point","volume":"15","author":"Liu","year":"2024","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-026-10208-0","article-title":"Facile induction of immune tolerance by an interleukin-2-TGF\u03b2 surrogate agonist","author":"Sun","year":"2026","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1111\/ajt.13883","article-title":"Impact of human mutant TGF\u03b21\/Fc protein on memory and regulatory T cell homeostasis following lymphodepletion in nonhuman primates","volume":"16","author":"Guo","year":"2016","journal-title":"Am J Transplant"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0800928105","article-title":"T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR","volume":"105","author":"Sauer","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2016.09.153","article-title":"TGF-\u03b2-induced phosphorylation of Akt and Foxo transcription factors negatively regulates induced regulatory T cell differentiation","volume":"480","author":"Kurebayashi","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.865593","article-title":"Tissue resident Foxp3(+) regulatory T cells: sentinels and saboteurs in health and disease","volume":"13","author":"Lee","year":"2022","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1177\/09636897231177377","article-title":"Interleukin-33 potentiates TGF-\u03b2 signaling to regulate intestinal stem cell regeneration after radiation injury","volume":"32","author":"Guan","year":"2023","journal-title":"Cell Transplant"},{"key":"B40","doi-asserted-by":"publisher","first-page":"18172","DOI":"10.1038\/s41598-025-03260-9","article-title":"Targeting of the IL-33\/Wnt axis restricts breast cancer stemness and metastasis","volume":"15","author":"Fan","year":"2025","journal-title":"Sci Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1177\/15353702221102094","article-title":"The role of IL-33\/ST2 signaling in the tumor microenvironment and Treg immunotherapy","volume":"247","author":"Lei","year":"2022","journal-title":"Exp Biol Med (Maywood)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.750542","article-title":"Regulatory T cells: regulation of identity and function","volume":"12","author":"Grover","year":"2021","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1331846","article-title":"Deciphering the developmental trajectory of tissue-resident Foxp3(+) regulatory T cells","volume":"15","author":"Alvarez","year":"2024","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.609891","article-title":"Targeted de-methylation of the FOXP3-TSDR is sufficient to induce physiological FOXP3 expression but not a functional Treg phenotype","volume":"11","author":"Kressler","year":"2020","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2424733122","article-title":"OGG1 augments the transcriptional activation of Foxp3 to promote iTreg differentiation for IBD alleviation","volume":"122","author":"Tian","year":"2025","journal-title":"Proc Natl Acad Sci USA"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1922600117","article-title":"Epigenetic conversion of conventional T cells into regulatory T cells by CD28 signal deprivation","volume":"117","author":"Mikami","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1502352","article-title":"Vitamin C facilitates demethylation of the Foxp3 enhancer in a Tet-dependent manner","volume":"196","author":"Sasidharan Nair","year":"2016","journal-title":"J Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20232068","article-title":"Dynamic Foxp3-chromatin interaction controls tunable Treg cell function","volume":"221","author":"He","year":"2024","journal-title":"J Exp Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17010155","article-title":"Metabolic signaling in the tumor microenvironment","volume":"17","author":"Clay","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.2340\/1651-226x.2024.33008","article-title":"The tumor immune microenvironment in breast cancer progression","volume":"63","author":"Otterlei Fj\u00f8rtoft","year":"2024","journal-title":"Acta Oncol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e37217","article-title":"Targeting tumor-associated macrophages with nanocarrier-based treatment for breast cancer: A step toward developing innovative anti-cancer therapeutics","volume":"10","author":"Muteeb","year":"2024","journal-title":"Heliyon"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13236012","article-title":"The immune landscape of breast cancer: Strategies for overcoming immunotherapy resistance","volume":"13","author":"Retecki","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B53","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12964-021-00775-2","article-title":"Aiduqing formula inhibits breast cancer metastasis by suppressing TAM\/CXCL1-induced Treg differentiation and infiltration","volume":"19","author":"Li","year":"2021","journal-title":"Cell Commun Signal"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-08-2360","article-title":"Regulatory T cells recruited through CCL22\/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome","volume":"69","author":"Gobert","year":"2009","journal-title":"Cancer Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1186\/s12885-018-5117-8","article-title":"CCL1 is a major regulatory T cell attracting factor in human breast cancer","volume":"18","author":"Kuehnemuth","year":"2018","journal-title":"BMC Cancer"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/nature10169","article-title":"Tumor hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells","volume":"475","author":"Facciabene","year":"2011","journal-title":"Nature"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12409","article-title":"Hypoxia-induced CCL28 promotes recruitment of regulatory T cells and tumor growth in liver cancer","volume":"7","author":"Ren","year":"2016","journal-title":"Oncotarget"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1017\/erm.2022.28","article-title":"Roles of CCR10\/CCL27-CCL28 axis in tumor development: mechanisms, diagnostic and therapeutic approaches, and perspectives","volume":"24","author":"Mergia Terefe","year":"2022","journal-title":"Expert Rev Mol Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102395","article-title":"Insights into the relevance of targeting fibroblasts to control cancer","volume":"6","author":"Boeker","year":"2025","journal-title":"Cell Rep Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1194835","article-title":"The role of cancer-associated fibroblasts in breast cancer metastasis","volume":"13","author":"Li","year":"2023","journal-title":"Front Oncol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.887380","article-title":"Cancer associated fibroblasts - An impediment to effective anti-cancer T cell immunity","volume":"13","author":"Koppensteiner","year":"2022","journal-title":"Front Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10585-008-9210-2","article-title":"Role of the CXCR4\/CXCL12 signaling axis in breast cancer metastasis to the brain","volume":"27","author":"Hinton","year":"2010","journal-title":"Clin Exp Metastasis"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34084","article-title":"Regulatory T cells: Their role in triple-negative breast cancer progression and metastasis","volume":"128","author":"Malla","year":"2022","journal-title":"Cancer"},{"key":"B64","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41419-025-07544-w","article-title":"Regulatory T cells in solid tumor immunotherapy: effect, mechanism and clinical application","volume":"16","author":"Pan","year":"2025","journal-title":"Cell Death Dis"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2024.02.001","article-title":"Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancer","volume":"57","author":"Shouse","year":"2024","journal-title":"Immunity"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1172\/jci178960","article-title":"Treg activation during allograft tolerance induction requires mitochondrion-induced TGF-\u03b21 in type 1 conventional dendritic cells","volume":"135","author":"Schroth","year":"2025","journal-title":"J Clin Invest"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2010.01.014","article-title":"Enrichment of CCR6+Foxp3+ regulatory T cells in the tumor mass correlates with impaired CD8+ T cell function and poor prognosis of breast cancer","volume":"135","author":"Xu","year":"2010","journal-title":"Clin Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13045-025-01754-7","article-title":"Tertiary lymphoid structures in cancer: spatiotemporal heterogeneity, immune orchestration, and translational opportunities\u200b\u200b","volume":"18","author":"Deng","year":"2025","journal-title":"J Hematol Oncol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2025.1561464","article-title":"Extracellular vesicles in triple-negative breast cancer: current updates, challenges and future prospects","volume":"12","author":"Tiwari","year":"2025","journal-title":"Front Mol Biosci"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1760782","article-title":"Reprogramming the immunosuppressive breast cancer microenvironment: integrating cellular, metabolic, and stromal targets for rational immunotherapy","volume":"17","author":"Ma","year":"2026","journal-title":"Front Immunol"},{"key":"B71","article-title":"ICOSL expressed in triple-negative breast cancer can induce Foxp3+ Treg cell differentiation and reverse p38 pathway activation","volume":"12","author":"Ma","year":"2022","journal-title":"Am J Cancer Res"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71467","article-title":"Inducible T-cell co-stimulator (ICOS) and ICOS ligand: dealing with a two-faced cancer immunoregulatory system","volume":"15","author":"Nikanjam","year":"2026","journal-title":"Cancer Med"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-024-03043-y","article-title":"Suppression of lysosome metabolism-meditated GARP\/TGF-\u03b21 complexes specifically depletes regulatory T cells to inhibit breast cancer metastasis","volume":"43","author":"Ma","year":"2024","journal-title":"Oncogene"},{"key":"B74","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41698-026-01338-9","article-title":"COL3A1(high) cancer-associated fibroblasts orchestrate metabolic and immune microenvironments to confer chemoresistance in breast cancer","volume":"10","author":"Jiang","year":"2026","journal-title":"NPJ Precis Oncol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jconrel.2016.12.012","article-title":"CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice","volume":"246","author":"Jadidi-Niaragh","year":"2017","journal-title":"J Control Release"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1061789","article-title":"Facts and perspectives: Implications of tumor glycolysis on immunotherapy response in triple negative breast cancer","volume":"12","author":"Schreier","year":"2022","journal-title":"Front Oncol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.212.supp.1394.5643","article-title":"Dysfunction of exhausted T cells is enforced by MCT11-mediated lactate metabolism","volume":"25","author":"Peralta","year":"2024","journal-title":"Nat Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-24-3283","article-title":"Proliferation of tumor-related regulatory T cells in circulation dictates efficacy of chemoimmunotherapy in triple-negative breast cancer","volume":"31","author":"Jeon","year":"2025","journal-title":"Clin Cancer Res"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-03045-2","article-title":"Metabolic support of tumor-infiltrating regulatory T cells by lactic acid","volume":"591","author":"Watson","year":"2021","journal-title":"Nature"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2026.03.015","article-title":"Identification of cycling regulatory T cell precursors as conductors of immune escape during breast carcinoma progression","author":"Bui","year":"2026","journal-title":"Cancer Cell"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-23-0613","article-title":"CD25high effector regulatory T cells hamper responses to PD-1 blockade in triple-negative breast cancer","volume":"83","author":"Fattori","year":"2023","journal-title":"Cancer Res"},{"key":"B82","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.immuni.2025.11.020","article-title":"Positioning and reversible suppression of CCR7(+) dendritic cells in perivascular tumor niches shape cancer immunity","volume":"59","author":"Zitti","year":"2026","journal-title":"Immunity"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008219","article-title":"Blocking senescence and tolerogenic function of dendritic cells induced by \u03b3\u03b4 Treg cells enhances tumor-specific immunity for cancer immunotherapy","volume":"12","author":"Si","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B84","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ijbiomac.2018.06.033","article-title":"LncRNA SNHG1 regulates the differentiation of Treg cells and affects the immune escape of breast cancer via regulating miR-448\/IDO","volume":"118","author":"Pei","year":"2018","journal-title":"Int J Biol Macromol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-10-4316","article-title":"Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4+ T cells to T-regulatory cells","volume":"71","author":"Olkhanud","year":"2011","journal-title":"Cancer Res"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2020.11049","article-title":"CCL11 increases the proportion of CD4+CD25+Foxp3+ Treg cells and the production of IL-2 and TGF-\u03b2 by CD4+ T cells via the STAT5 signaling pathway","volume":"21","author":"Wang","year":"2020","journal-title":"Mol Med Rep"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.08.014","article-title":"Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance","volume":"27","author":"Cao","year":"2007","journal-title":"Immunity"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.91599","article-title":"Human regulatory T cells undergo self-inflicted damage via granzyme pathways upon activation","volume":"2","author":"Sula Karreci","year":"2017","journal-title":"JCI Insight"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgg.2024.09.014","article-title":"Improving regulatory T cell-based therapy: insights into post-translational modification regulation","volume":"52","author":"Wang","year":"2025","journal-title":"J Genet Genomics"},{"key":"B90","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev-cancerbio-042920-104912","article-title":"The multifaceted role of regulatory T cells in breast cancer","volume":"5","author":"Kos","year":"2021","journal-title":"Annu Rev Cancer Biol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1186\/s12967-025-07370-w","article-title":"Recent progress in immune evasion mechanisms of triple-negative breast cancer","volume":"23","author":"Yang","year":"2025","journal-title":"J Transl Med"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2026.03.007","article-title":"Treg-directed cancer immunotherapy beyond immune checkpoints: progress and opportunities","author":"Xie","year":"2026","journal-title":"Trends Pharmacol Sci"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03326-4","article-title":"CTLA-4 blockade drives loss of T(reg) stability in glycolysis-low tumors","volume":"591","author":"Zappasodi","year":"2021","journal-title":"Nature"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2023.2201147","article-title":"Neoadjuvant immune checkpoint blockade triggers persistent and systemic T(reg) activation which blunts therapeutic efficacy against metastatic spread of breast tumors","volume":"12","author":"Blomberg","year":"2023","journal-title":"Oncoimmunology"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.12.006","article-title":"Regulatory T cells control antigen-specific expansion of Tfh cell number and humoral immune responses via the coreceptor CTLA-4","volume":"41","author":"Wing","year":"2014","journal-title":"Immunity"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.206.supp.96.04","article-title":"Treg-expressed CTLA-4 depletes CD80\/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells","volume":"118","author":"Tekguc","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1172\/jci171154","article-title":"PD-1 or CTLA-4 blockade promotes CD86-driven Treg responses upon radiotherapy of lymphocyte-depleted cancer in mice","volume":"134","author":"Frijlink","year":"2024","journal-title":"J Clin Invest"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellin.2024.100146","article-title":"PD-1-mediated inhibition of T cell activation: Mechanisms and strategies for cancer combination immunotherapy","volume":"3","author":"Liu","year":"2024","journal-title":"Cell Insight"},{"key":"B99","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3233\/bd-249006","article-title":"PD-1\/PD-L1 pathway: Current research in breast cancer","volume":"43","author":"Syamsu","year":"2024","journal-title":"Breast Dis"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1383456","article-title":"Targeting PD-1\/PD-L-1 immune checkpoint inhibition for cancer immunotherapy: success and challenges","volume":"15","author":"Javed","year":"2024","journal-title":"Front Immunol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"38901","DOI":"10.1038\/s41598-025-22658-z","article-title":"Serpina1 gene regulates the tumorigenesis and progression of breast cancer through PI3K\/AKT signaling pathway and tumor immune microenvironment","volume":"15","author":"Lei","year":"2025","journal-title":"Sci Rep"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113059","article-title":"Pirfenidone inhibits CCL2-mediated Treg chemotaxis induced by palbociclib and fulvestrant in HR+\/HER2- breast cancer","volume":"142","author":"Li","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s43556-025-00345-9","article-title":"Cd39 and cd73: biological functions, diseases and therapy","volume":"6","author":"Shen","year":"2025","journal-title":"Mol BioMed"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1427380","article-title":"Current perspectives and trends of CD39-CD73-eAdo\/A2aR research in tumor microenvironment: a bibliometric analysis","volume":"15","author":"Huang","year":"2024","journal-title":"Front Immunol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104753","article-title":"Inhibition of breast cancer resistance protein (ABCG2) in human myeloid dendritic cells induces potent tolerogenic functions during LPS stimulation","volume":"9","author":"Jin","year":"2014","journal-title":"PloS One"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.7150\/thno.105857","article-title":"Atp released by ultrasound targeted microbubble cavitation induces vascular inflammation and improves immune checkpoint blockade efficacy","volume":"15","author":"Jahangiri","year":"2025","journal-title":"Theranostics"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpt.2023.11.001","article-title":"Role of indoleamine 2, 3-dioxygenase 1 in immunosuppression of breast cancer","volume":"2","author":"Sarangi","year":"2024","journal-title":"Cancer Pathog Ther"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v11.i12.1018","article-title":"Forkhead box P3 and indoleamine 2,3-dioxygenase co-expression in Pakistani triple negative breast cancer patients","volume":"11","author":"Asghar","year":"2020","journal-title":"World J Clin Oncol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121180","article-title":"A novel prodrug and its nanoformulation suppress cancer stem cells by inducing immunogenic cell death and inhibiting indoleamine 2, 3-dioxygenase","volume":"279","author":"Guan","year":"2021","journal-title":"Biomaterials"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.15171\/apb.2015.036","article-title":"Increased P-35, EBI3 transcripts and other Treg markers in peripheral blood mononuclear cells of breast cancer patients with different clinical stages","volume":"5","author":"Hamidinia","year":"2015","journal-title":"Adv Pharm Bull"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2024.156834","article-title":"The possible anti-tumor effects of regulatory T cells plasticity \/ IL-35 in the tumor microenvironment of the major three cancer types","volume":"186","author":"Khalil","year":"2025","journal-title":"Cytokine"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1051282","article-title":"The role of IL-35 and IL-37 in breast cancer - potential therapeutic targets for precision medicine","volume":"12","author":"Ma","year":"2022","journal-title":"Front Oncol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1457189","article-title":"Regulatory T cells: masterminds of immune equilibrium and future therapeutic innovations","volume":"15","author":"Ge","year":"2024","journal-title":"Front Immunol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1007\/s12672-025-03797-1","article-title":"Microenvironmental regulation and remodeling of breast cancer angiogenesis: from basic mechanisms to clinical therapeutic implications","volume":"16","author":"Zhou","year":"2025","journal-title":"Discov Oncol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-023-01744-8","article-title":"Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments","volume":"22","author":"Yuan","year":"2023","journal-title":"Mol Cancer"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-024-00714-6","article-title":"Towards targeting the breast cancer immune microenvironment","volume":"24","author":"Harris","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2024.102831","article-title":"The landscape of combining immune checkpoint inhibitors with novel therapies: secret alliances against breast cancer","volume":"130","author":"Rebaudi","year":"2024","journal-title":"Cancer Treat Rev"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-008898","article-title":"Tnfr2 blockade promotes antitumoral immune response in PDAC by targeting activated Treg and reducing T cell exhaustion","volume":"12","author":"Debesset","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110447","article-title":"Tumor-educated T(regs) drive organ-specific metastasis in breast cancer by impairing NK cells in the lymph node niche","volume":"38","author":"Kos","year":"2022","journal-title":"Cell Rep"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2009.04018.x","article-title":"Depletion of CD4+CD25+ regulatory T cells enhances natural killer T cell-mediated anti-tumor immunity in a murine mammary breast cancer model","volume":"159","author":"Hong","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156188","article-title":"EChinacoside inhibits tumor immune evasion by downregulating inducible PD-L1 and reshaping tumor immune landscape in breast and colorectal cancer","volume":"135","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"key":"B122","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s40001-024-01901-9","article-title":"Targeting cytotoxic lymphocyte antigen 4 (CTLA-4) in breast cancer","volume":"29","author":"Jama","year":"2024","journal-title":"Eur J Med Res"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-012829","article-title":"Anti-HER2\u00d7CCR4 bispecific antibody enhances antitumor immunity in advanced HER2-positive tumors by chemotaxis blockade and depletion of tumor-associated Tregs, without inducing systemic toxicity","volume":"13","author":"Wang","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1316796110","article-title":"Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans","volume":"110","author":"Sugiyama","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1820388116","article-title":"Depletion of regulatory T cells in tumors with an anti-CD25 immunotoxin induces CD8 T cell-mediated systemic antitumor immunity","volume":"116","author":"Onda","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.12003","article-title":"Microrna-126 regulates the induction and function of CD4(+) Foxp3(+) regulatory T cells through PI3K\/AKT pathway","volume":"17","author":"Qin","year":"2013","journal-title":"J Cell Mol Med"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-011-1647-3","article-title":"CD8+ cytotoxic T cell and FOXP3+ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes","volume":"130","author":"Liu","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-012-2110-9","article-title":"Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells","volume":"138","author":"Tiriveedhi","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"B129","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00262-013-1490-y","article-title":"Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression","volume":"63","author":"Whiteside","year":"2014","journal-title":"Cancer Immunol Immunother"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.4161\/onci.23129","article-title":"Cox2 regulation of breast cancer bone metastasis","volume":"2","author":"Karavitis","year":"2013","journal-title":"Oncoimmunology"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-24-0729","article-title":"KIR2DL2\/DL3+NKs and Helios+Tregs in peripheral blood predict nivolumab response in patients with metastatic renal cell cancer","volume":"30","author":"Santagata","year":"2024","journal-title":"Clin Cancer Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1825637\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T06:03:45Z","timestamp":1779775425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1825637\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":131,"alternative-id":["10.3389\/fimmu.2026.1825637"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1825637","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"article-number":"1825637"}}